HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Trade Groups, Emord Rip FTC Interpretation Of POM Wonderful Ads

This article was originally published in The Tan Sheet

Executive Summary

An amici curiae brief filed in the POM Wonderful case by CHPA and CRN criticizes FTC for relying “on its own ‘expertise’ to determine the meaning of ambiguous advertisements.” A separate brief by attorney Jonathan Emord says FTC is creating unreasonable barriers for food product research.

You may also be interested in...



POM Wonderful Asks Court To Vacate “Draconian” FTC Order

The nearly three-year battle between FTC and POM Wonderful moves to a federal appeals court, where the pomegranate juice and supplement firm asks the judges to nix the commission’s order that POM conduct two randomized controlled trials to support disease-related health claims.

POM Wonderful Misses Mark In Suit On FTC Claims Standard, Attorneys Say

A complaint challenging Federal Trade Commission claim substantiation requirements could backfire and strengthen the agency's rulemaking authorities, a food and drug attorney says

FTC's Pending Claim Substantiation Changes Will Weigh On Small Firms

The Federal Trade Commission soon will demand greater substantiation for dietary supplement health claims as the agency aligns its standards for clinical evidence more closely with FDA's

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS124151

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel